Exploring the immune profile of chronic hand eczema
Official title: Characterization of the Immune Signature of Chronic Hand Eczema With an Innovative Approach Combining Spatial Transcriptomics and Single Cell Spatial Proteomics
Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06884163 · Data updated 2026-11-12
This study is trying to understand the immune system's response in adults with chronic hand eczema to help create better, personalized treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS Academic / other |
| Locations | 1 site (Rome) |
| Status | Recruiting |
| Started | January 13, 2025 |
| Main results expected | January 1, 2026 |
| Study ends | January 1, 2027 |
| Registry record updated | March 19, 2025 |
| Trial ID | NCT06884163 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 65 with chronic hand eczema lasting at least 3 months or experiencing multiple flare-ups in the past year.
✕Probably not a fit
Patients currently using immunosuppressants or systemic corticosteroids may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the immune landscape of chronic hand eczema through advanced techniques like spatial transcriptomics and single-cell proteomics. It includes patients aged 18 to 65 with chronic hand eczema, assessing disease severity using validated scores and conducting skin biopsies for diagnosis confirmation. The research aims to identify distinct inflammatory cell subgroups and molecular markers that characterize the immune response in various subtypes of chronic hand eczema, potentially leading to more personalized treatment strategies.
Why it matters
Potential benefit: If successful, this research could lead to more effective and tailored therapies for patients suffering from chronic hand eczema.
How similar studies have gone: While this approach is innovative, similar studies have shown promise in understanding immune responses in other dermatological conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients affected with chronic hand eczema of endogenous and/or exogenous origin, age from 18 to 65 years * Patients affected with eczema located on the hands for at least 3 months or with ≥ 2 disease flare-ups in the last year. * Patients affected with atopic dermatitis affecting the hands and other areas of the body, provided the eczema lesions involve less than 30% of the body surface area. Exclusion Criteria: * Concurrent or previous treatment with immunosuppressants, except for short courses of systemic corticosteroids (less than one month of continuous treatment), or biologic agents that may affect the clinical aspects or progression of chronic hand eczema. * Patients who have received systemic corticosteroids within one month prior to enrollment in the study. * Patients using topical corticosteroids or calcineurin inhibitors within one week of study enrollment (this time frame is considered to provide a good balance between potential residual pharmacological effects and ethical considerations). * Patients with chronic hand eczema of mixed etiology (e.g., allergic and atopic) or those considered "etiologically unclassifiable" will not be included in the data analysis.
Where it's running
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, Italy Recruiting
Study contacts
- Principal investigator: Ketty Peris, Prof — Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Study coordinator: Ketty Peris, Prof
- Email: ketty.peris@policlinicogemelli.it
- Phone: +390630155284
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How cinema sessions during chemotherapy might help cervical cancer patients
We’re testing if watching films during chemotherapy helps cervical cancer patients feel less anxious and improve quality of life.
-
Ophthalmic Artery Doppler to predict labor problems before induction
This study tests whether measuring the ophthalmic artery Doppler in pregnant people at term who are being induced can help predict intrapartum fetal distress.
-
GCP-R3 Practice Survey for Italian Clinical Researchers
Researchers in Italy are taking a web survey to see how well they understand and apply GCP E6(R3) and to identify barriers and training needs.
-
Longitudinal profiling of plasma-derived glial extracellular vesicles in Alzheimer's disease
This study tests whether plasma glial extracellular vesicles and neuroinflammation biomarkers change over time across the Alzheimer’s disease spectrum and whether these signals relate to amyloid, tau, and neurodegeneration, with an additional step of exposing healthy iPSC-derived neurons to vesicles to see potential ne
-
Amniotic Fluid DNA sequencing to detect infection in women with short cervix or PROM
This study tests a nanopore DNA sequencing method on amniotic fluid to see if it more reliably detects infection and inflammation than standard bacterial cultures in pregnant women with short cervix or premature rupture of membranes.
-
Insomnia and Post-Dental Surgery Pain: A Look at Sleep Quality and Pain After Tooth Extractions
This study tests whether preoperative sleep problems influence how much pain people feel after routine tooth extractions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.